Effects of hyaluronan on models of immediate and delayed hypersensitivity in the rat

International Journal of Immunopharmacology

Volumn 21, Issue 3, 1999, Pages 195-203

  Moore, A R ^a   Gilroy, D W ^a   Colville Nash, P R ^a   Greenslade, K ^a   Asculai, S ^a   Willoughby, D A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antigen masking; Hyaluronan; Hypersensitivity reactions

Indexed keywords

BOVINE SERUM ALBUMIN; EPITOPE; FREUND ADJUVANT; HYALURONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHUS PHENOMENON; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOMODULATION; INFLAMMATORY CELL; INTRAPLEURAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

ANIMALS; ARTHUS REACTION; DISEASE MODELS, ANIMAL; HYALURONIC ACID; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; INJECTIONS, INTRAVENOUS; MALE; RABBITS; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE;

EID: 0033002283     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00081-2     Document Type: Article

References (18)

1. Beck, D. E. (1997). The role of Seprafilm bioresorbable membrane in adhesion prevention. Eur. J. Surg. Suppl., 577, 49-55.
2. Butler, J., Rydell, N. W., and Balazs, E. A. (1970). Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet. Scand. 11, 139-155.
3. Camp, R. L., Scheynnius, A., Johansson, C., and Pure, E. (1993). CD44 is necessary for optimal contact allergic responses but is not required for normal leucocyte extravasation. J. Exp. Med. 178, 497-507.
4. Cascone, M. G., Sim, B., and Downes, S. (1995). Blends of synthetic and natural polymers as drug delivery systems for growth hormone. Biomaterials, 16, 569-574.
5. Cashin, C. H., Gill, J., Jones, S. A., and Kennedy, A. J. (1979). An assessment of the delayed hypersensitivity reaction to methylated bovine serum albumin in the mouse and its use in the mouse and its use in the evaluation of drug effects on cell mediated immune reactions. Agents Actions, 9, 553-539.
6. Ialenti, A., and Di Rosa, M. (1994). Hyaluronic acid modulates acute and chronic inflammation. Agents Actions, 43, 44-47.
7. Lesley, J., Howes, N., Perschl, A., and Hyman R. (1994). Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med., 180, 383-387.
8. Miller, D., and Stegmann, R. (1982). The use of Healon in intraocular lens implantation. Int. Ophthalmol. Clin., 22, 177-187.
9. Moore, A. R., and Willoughby, D. A. (1995). Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int. J. Tissue React., 17, 153-156.
10. hi population that binds specifically to hyaluronate. J. Immunol., 146, 1422-1427.
11. Murakami, S., Miyaki, K., June, C. H., Kincade, P. W., and Hodges, R. J. (1990). IL-5 induces Pgp-1 (CD44) bright B cell sub-population that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol, 145, 3618-3627.
12. Peyron, J. G. (1993). Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J. Rheumatol. Suppl., 39, 10-15.
13. Sakurai, K., Miyazaki, K., Kodera, Y., Nishimura, H., Shingu, M., and Inada, Y. (1997). Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate. Glycoconj. J., 14, 723-728.
14. Sato, H., Takahashi, T., Ide, H., Fukushima, T., Tabata, M., Sekine, F., Kobayashi, K., Negishi, M., and Niwa, Y. (1988). Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum., 31, 63-71.
15. Seed, M. P., Alam, C. A. S., Brown, J., Freemantle, C. N., and Willoughby, D. A. (1995). The delivery of diclofenac to pathological tissues by hyaluronan (HYAL EX-0001). RSM Round Table Ser., 40, 74-81.
16. Trowbridge, I. S., Lesley, J., Schulte, R. Hyman, R., and Trotter, J. (1982). Biochemical characterisation and cellular distribution of polymorphic murine cell surface glycoprotein expressed on lymphoid tissues. Immunogenetics, 15, 299-312.
17. Verdrengh, M., Holmdahl, R., and Tarkowski, A. (1995). Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand. J. Immunol., 42, 353-358.
18. Yerushalmi, N., Arad, A., and Margalit, R. (1994). Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch. Biochem. Biophys., 313, 267-273.